<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01014273</url>
  </required_header>
  <id_info>
    <org_study_id>Rad-Fem PCI Access Study</org_study_id>
    <nct_id>NCT01014273</nct_id>
  </id_info>
  <brief_title>A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy</brief_title>
  <acronym>RIVAL</acronym>
  <official_title>An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy. An Extension to the CURRENT (OASIS 7) Substudy (EFC5695): Effect of Type of Access for PCI (Radial or Femoral) on Bleeding Rate-Substudy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-national, multi-centre, randomized study comparing the trans-radial PCI&#xD;
      access strategy and the trans-femoral PCI access strategy in ACS patients with UA or NSTEMI&#xD;
      or STEMI planned to be treated with an invasive strategy (PCI).&#xD;
&#xD;
      The hypothesis is that radial access site PCI will be associated with significantly less&#xD;
      major bleeding and access site complications compared with a femoral approach, without&#xD;
      increasing the risk of ischemic events. The overall benefit-risk profile will favor a&#xD;
      trans-radial approach.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First occurrence of the composite of death, MI, stroke or non CABG major bleeding (i.e. severe bleeding, other major bleeding) at 30 days.</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non CABG major bleeding</measure>
    <time_frame>within 30 days following randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death, MI or stroke</measure>
    <time_frame>within 30 days following randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7021</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>Trans-femoral access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Femoral artery PCI access site</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trans-radial access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radial artery PCI access site</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous Coronary Intervention</intervention_name>
    <arm_group_label>Trans-femoral access</arm_group_label>
    <arm_group_label>Trans-radial access</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
        1.1 UA/NSTEMI patients&#xD;
&#xD;
        Ischemic symptoms suspected to represent a non-ST segment elevation ACS (unstable angina&#xD;
        [UA] or non-ST segment elevation myocardial infarction NSTEMI) defined as:&#xD;
&#xD;
        Clinical history consistent with new onset, or a worsening pattern, of characteristic&#xD;
        ischemic chest pain occurring at rest or with minimal exercise (lasting longer than 10&#xD;
        minutes) and planned to be managed with an invasive strategy&#xD;
&#xD;
        AND at least one of the following:&#xD;
&#xD;
          1. Electrocardiogram (ECG) changes compatible with new ischemia [ST depression of at&#xD;
             least 1mm or transient ST elevation or ST elevation of less than or equal to 1 mm or T&#xD;
             wave inversion greater than 2 mm in at least 2 contiguous leads].&#xD;
&#xD;
             or&#xD;
&#xD;
          2. Patients &gt; 60 years of age with normal ECG are eligible provided there is a high&#xD;
             degree of certainty that presenting symptoms are due to myocardial ischemia. Such&#xD;
             patients must have documented evidence of previous coronary artery disease (CAD) with&#xD;
             at least one of the following:&#xD;
&#xD;
               -  Prior MI requiring hospitalization&#xD;
&#xD;
               -  Prior revascularization procedure (more than 3 months ago)&#xD;
&#xD;
               -  Cardiac catheterization showing significant CAD&#xD;
&#xD;
               -  Positive exercise test&#xD;
&#xD;
               -  Other objective evidence of atherosclerotic vascular disease or&#xD;
&#xD;
          3. Already elevated cardiac enzymes or troponin I or T above the upper limit of normal.&#xD;
&#xD;
        1.2 STEMI patients&#xD;
&#xD;
          1. Presenting with signs or symptoms of acute myocardial infarction lasting at least 20&#xD;
             minutes and planned to be managed with an invasive strategy with intent to perform a&#xD;
             percutaneous coronary intervention (PCI) during the index hospitalization.&#xD;
&#xD;
          2. Definite ECG changes compatible with STEMI: persistent ST-elevation (&gt; 2 mm in two&#xD;
             contiguous precordial leads or &gt; 1 mm in at least two limb leads), or new left bundle&#xD;
             branch block, or Q-wave in 2 contiguous leads&#xD;
&#xD;
             2) Randomized during index hospitalization for acute coronary syndrome 3) Suitable&#xD;
             candidate for either radial or femoral artery PCI 4) Intent to perform same-sitting&#xD;
             angiography and PCI. 5) Palpable radial artery with documented normal Allen's test 6)&#xD;
             Acceptance by operator to use whichever route is assigned by the randomization process&#xD;
             7) Previous experience of the operator with at least 50 cases of radial artery access&#xD;
             within the past year 8) Written informed consent&#xD;
&#xD;
             EXCLUSION CRITERIA&#xD;
&#xD;
               1. Age &lt; 18 years&#xD;
&#xD;
               2. Active bleeding or significant increased risk of bleeding, severe hepatic&#xD;
                  insufficiency, current peptic ulceration, proliferative diabetic retinopathy.&#xD;
&#xD;
               3. Uncontrolled hypertension&#xD;
&#xD;
               4. Cardiogenic shock&#xD;
&#xD;
               5. Prior CABG surgery with use of more than one internal mammary artery&#xD;
&#xD;
               6. Documented severe peripheral vascular disease precluding a femoral approach&#xD;
&#xD;
               7. Participation in any study with an investigational drug or device within the&#xD;
                  previous 30 days&#xD;
&#xD;
               8. Medical, geographic or social factors making study participation impractical&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjit Jolly, MD, MSc, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan Chrolavicius</last_name>
    <role>Study Director</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shamir Mehta, MD, MSc, FRCP(C), FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <study_first_submitted>November 13, 2009</study_first_submitted>
  <study_first_submitted_qc>November 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2009</study_first_posted>
  <last_update_submitted>April 6, 2011</last_update_submitted>
  <last_update_submitted_qc>April 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Sanjit Jolly, MD, MSc, FRCPC</name_title>
    <organization>Population Health Research Institute</organization>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>PCI</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Radial Access</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

